Stage III Colorectal Cancer
Information
- Disease name
- Stage III Colorectal Cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04007770 | Active, not recruiting | Phase 2 | Acupuncture Pilot Study for Cancer-related Cognitive Function | July 1, 2019 | July 2025 |
| NCT02842203 | Active, not recruiting | Use of ctDNA for Monitoring of Stage III Colorectal Cancer | September 2016 | September 2025 | |
| NCT05025748 | Completed | N/A | Ask Questions (ASQ):Implementation of a Communication Intervention | August 25, 2021 | August 31, 2022 |
| NCT03112668 | Completed | N/A | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | December 6, 2017 | January 25, 2018 |
| NCT03095781 | Completed | Phase 1 | Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer | July 7, 2017 | June 10, 2021 |
| NCT03127111 | Not yet recruiting | Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer | December 1, 2022 | December 31, 2026 | |
| NCT05954078 | Recruiting | Phase 3 | Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer | August 1, 2023 | June 2028 |
| NCT06307548 | Recruiting | Phase 1/Phase 2 | Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer | June 1, 2024 | June 1, 2027 |
| NCT03368963 | Recruiting | Phase 1/Phase 2 | TAS102 in Combination With NAL-IRI in Advanced GI Cancers | January 30, 2018 | November 28, 2025 |
| NCT04589468 | Recruiting | N/A | Researching the Effect of Exercise on Cancer | October 2, 2020 | October 2, 2024 |
| NCT04624555 | Recruiting | The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors | June 30, 2024 | December 31, 2024 | |
| NCT05631574 | Recruiting | Phase 1 | Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer | January 12, 2023 | October 2026 |
| NCT05086614 | Recruiting | Phase 3 | Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer | April 1, 2021 | March 31, 2027 |
| NCT05161585 | Recruiting | N/A | Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study | November 1, 2021 | September 2024 |
| NCT04044430 | Terminated | Phase 1 | Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer | August 31, 2020 | July 31, 2022 |
| NCT04513431 | Unknown status | Early Phase 1 | A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC) | August 30, 2020 | August 30, 2023 |
| NCT02135887 | Unknown status | A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer. | November 4, 2013 | December 31, 2022 |